The patient's hematocrit and hemoglobin has been stable throughout the admission.
The patient also had an echocardiogram on [**2113-11-10**] which revealed a moderately dilated left atrium, moderately dilated right atrium and normal left ventricular function with an left ventricular ejection fraction of 50 to 55%, normal right ventricle, aortic valve leaflets, mildly thickened, no aortic regurgitation, a bioprosthetic mitral valve with no mitral regurgitation and tricuspid valve leaflets mildly thickened, valve annuloplasty ring present, moderate 2+ tricuspid regurgitation.
Note: patient has mosaic bioprosthetic MVR which does not require longterm anticoagulation.
Captopril 6.25 mg t.i.d.
Metoprolol 25 mg b.i.d.
Digoxin 0.125 mg q.d.
Prozac 40 mg q.d.
Ativan 0.5 mg q.h.s.
Colace 100 mg b.i.d.
Senna 1 tablet b.i.d.
Simethicone 80 mg q.i.d.
Salmeterol 1 puff b.i.d.
Fluticasone 220 mcg 2 puffs b.i.d.
Ocean nasal spray, one to two sprays, NU q.i.d.
Nystatin oral suspension 5 mg q.i.d.
Albuterol nebulizers q.
4 hours prn 15.
Ipratropium nebulizers q.
4 hours prn 16.
Prevacid 30 mg q.d.
via gastrostomy tube 17.
Guaifenesin 5 to 10 ml q.
6 hours prn 18.
Ceftriaxone 1 gm intravenously q.d., day #9 of 10, treatment to end on [**2113-11-15**] 19.
Lasix 20 mg q.d.
